ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical
need.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Robert Boyleweg 4, Biopartner 4,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.artica-tx.com
- HQ
- Leiden, South Holland
Artica Therapeutics Questions
Artica Therapeutics's website is http://www.artica-tx.com
Artica Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/artica-tx
Artica Therapeutics has
16 employees.
View email and phone details for 16
employees at Artica Therapeutics.
Artica Therapeutics's industry is
Biotechnology Research
Artica Therapeutics's top competitors are
Cellforcure By Seqens,
Reshape Biotech,
Syvento Biotech,
Draupnir Bio,
Quotient Therapeutics,
Nawter,
Neurosterix,
Adcytherix,
Amber Therapeutics,
Biow.
Artica Therapeutics's categories are Biotechnology Research
Artica Therapeutics's founding year is 2020
